Galit Alter
Galit Alter is an immunologist and virologist, professor of medicine at Harvard Medical School, and group leader at the Ragon Institute of MGH, MIT and Harvard.
She is known for her work on the expansion of particular natural killer cell subtypes in response to HIV-1 infection. She has also contributed to the understanding of how SARS-CoV-2 antibody titers correlate with sustained humoral protection, including identifying coordinated immune cell-antibody signatures that may predict COVID-19 infection outcome.
Galit Alter | |
|---|---|
| Born | 1976 or 1977 (age 46–47) |
| Education | Ph.D. from McGill University |
| Awards | MGH Research Scholars Award (twice) |
| Scientific career | |
| Fields | immunology, infectious diseases |
| Institutions | Harvard Medical School Ragon Institute |
| Website | ragoninstitute |
In October 2022 she became Vice President of Moderna
References
This article uses material from the Wikipedia English article Galit Alter, which is released under the Creative Commons Attribution-ShareAlike 3.0 license ("CC BY-SA 3.0"); additional terms may apply (view authors). Content is available under CC BY-SA 4.0 unless otherwise noted. Images, videos and audio are available under their respective licenses.
®Wikipedia is a registered trademark of the Wiki Foundation, Inc. Wiki English (DUHOCTRUNGQUOC.VN) is an independent company and has no affiliation with Wiki Foundation.